Evidence map›Paper›PMID 30746392›Full record

ArticleJournal of medical imaging (Bellingham, Wash.)2019

Adaptive Bayesian label fusion using kernel-based similarity metrics in hippocampus segmentation.

David Cárdenas-Peña, Andres Tobar-Rodríguez, German Castellanos-Dominguez, Alzheimer's Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in Journal of medical imaging (Bellingham, Wash.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David Cárdenas-PeñaUniversidad Nacional de Colombia, Signal Processing and Recognition Group, Manizales, Colombia.ORCID https://orcid.org/0000-0002-0522-8683
Andres Tobar-RodríguezUniversidad Nacional de Colombia, Signal Processing and Recognition Group, Manizales, Colombia.
German Castellanos-DominguezUniversidad Nacional de Colombia, Signal Processing and Recognition Group, Manizales, Colombia.
Alzheimer's Disease Neuroimaging InitiativeUniversidad Nacional de Colombia, Signal Processing and Recognition Group, Manizales, Colombia.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

The effectiveness of brain magnetic resonance imaging (MRI) as a useful evaluation tool strongly depends on the performed segmentation of associated tissues or anatomical structures. We introduce an enhanced brain segmentation approach of Bayesian label fusion that includes the construction of adaptive target-specific probabilistic priors using atlases ranked by kernel-based similarity metrics to deal with the anatomical variability of collected MRI data. In particular, the developed segmentation approach appraises patch-based voxel representation to enhance the voxel embedding in spaces with increased tissue discrimination, as well as the construction of a neighborhood-dependent model that addresses the label assignment of each region with a different patch complexity. To measure the similarity between the target and training atlases, we propose a tensor-based kernel metric that also includes the training labeling set. We evaluate the proposed approach, adaptive Bayesian label fusion using kernel-based similarity metrics, in the specific case of hippocampus segmentation of five benchmark MRI collections, including ADNI dataset, resulting in an increased performance (assessed through the Dice index) as compared to other recent works.

Indexed as

Bayesian segmentationbrain tissue segmentationinterslice kernel

Identifiers

PMID30746392
PMCPMC6361550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.